Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05875090Not ApplicableEnrolling By Invitation

Glaucoma Portugal Screening Trial

Role: collaborator

NCT05391646Not Yet Recruiting

Pulmonary Embolism Registry

Role: collaborator

NCT04492137Not ApplicableUnknown

Prospective Comparison Between Ultra Early NKF Versus Standard Cannulation Alone

Role: collaborator

NCT04492124Unknown

Influence of Vater's Ampulla Morphology on ERCP

Role: collaborator

All 4 trials loaded